Siemens CFO Ralf Thomas announced that the company is assessing its majority stake in its medical technology subsidiary, Siemens Healthineers. Thomas mentioned that the synergy between Siemens and the MRI and lab systems manufacturer does not justify the €45 billion ($46.91 billion) capital commitment, referring to Siemens' 75% stake in Healthineers.
He stated that Siemens is evaluating economic opportunities in healthcare to determine the investment's role, with conclusions expected by the end of 2025 during Siemens' Capital Markets Day. Siemens spun off Healthineers in 2018, maintaining a majority stake. However, Thomas recently indicated that Siemens might sell about 5% of Healthineers to fund the acquisition of U.S. software company Altair.
Thomas also reaffirmed Siemens' commitment to its Mobility train division, despite investor calls for divestiture, emphasizing the business's strategic value to Siemens.
